Here are three updates on gastroenterology and endoscopy companies.
Paris, France-based Nanobiotix reported the results of its phase I/II clinical trial for NBTXR3, its liver cancer drug.
Three senior Olympus executives utilized their right to invoke the Fifth Amendment during questioning over internal company emails.
Following news about superbug outbreaks at numerous facilities, providers and hospitals are trying out disposable scopes, such as Boston Scientific's single-use bronchoscope.